-2.png)
Kalman Tiboldi - CTO & Founder at GemOne-TVH - Simplify or Die: Why Complexity Is the Real IT Challenge
-2.png)
Germany Aug 27, 2025 Country Members Virtual german
Die neuen geo-politischen Veränderungen und unvorhergesehene wirtschaftliche Anforderungen stellen Digital Leader vor neue Herausforderungen. Immer öfter wird in den Vorstandsetagen die Frage gestellt, wie der (IT) Betrieb sicher und ungestört weiter funktionieren kann, wenn regionale Rechenzentren und Infrastrukturen plötzlich nicht mehr verfügbar oder nur teilweise noch einsatzbereit sind. Der CIO muss für diese neue Welt resiliente Strategien parat haben, die für Business Continuity in bisher nicht vorstellbaren politischen und wirtschaftlichen Szenarien ermöglichen.
Read More
Belgium Aug 28, 2025 Country Members Physical english
With the theme “The Power of Connection,” we’re embracing the essence of meaningful connections within IT and beyond. To honour our tradition, expect an unforgettable evening featuring keynote presentations, open bars, a summer BBQ, and a special experience designed to bring our vibrant community together.
Read More
Belgium Aug 28, 2025 Country Members Physical english
A special celebration marking 20 years of CIONET—two decades of empowering digital leaders and driving innovation in the technology landscape. This exclusive event will bring together our members to reflect on the incredible journey we've shared and look ahead to the future of digital leadership.Featuring keynote presentations from visionary CIOs, industry pioneers, and founding members, we’ll explore how far we’ve come and what lies ahead in the ever-evolving world of technology. Together, we will honour the contributions of our members who have shaped CIONET’s legacy while offering insights into how the community will continue to lead in the years to come.This is more than a celebration—it’s an opportunity to reconnect, reflect, and recharge with your fellow digital leaders. Don't miss this exclusive experience packed with inspiring talks, networking opportunities, and special recognitions that highlight the best of CIONET’s history and future.Let’s celebrate the past, present, and future of the digital community you helped build.
Read More.png)
-1.png)
Germany Sep 9, 2025 Country Members Physical german
Vom ersten Use Case zur strategischen Neuausrichtung CIONET lädt bereits zum vierten Mal zu einem exklusiven Roundtable für CIOs und Digitalverantwortliche aus Logistik und Handel ein. Im Mittelpunkt des Abends steht die Frage, wie Unternehmen ihre KI-Initiativen erfolgreich skalieren und aus ersten Use Cases echten strategischen Mehrwert schaffen. Microsoft 365 für Frontline Worker: Moderne Tools, die Mitarbeitende im Tagesgeschäft entlasten ServiceNow für Prozessintegration: Automatisierte End-to-End-Workflows – vom Schadensfall bis zur Retourenabwicklung KI-gestützte Disposition und Planung: Mit smarten Algorithmen zur optimierten Supply Chain Digitale Lieferketten und letzte Meile: Transparenz, Effizienz und Kundenzentrierung durchgängig gedacht
Read More
Belgium Sep 13, 2025 All Members Physical english
Join us for a wonderful ride. The ride is accessible to all levels of riders and doesn't require extensive technical skills. More information will follow soon. Looking forward to ride together!
Read More
Moderna and OpenAI partner to accelerate the development of life-saving treatments.
Moderna partners with OpenAI to deploy ChatGPT Enterprise to thousands of employees across the company. Now every function is empowered with AI, creating novel use cases and GPTs that accelerate and expand the impact of every team.
Moderna has been at the intersection of science, technology, and health for more than 10 years. Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines—with the COVID-19 vaccine being their most well-known breakthrough.
The company has partnered with OpenAI since early 2023. Now, ChatGPT Enterprise is evolving how Moderna operates across each function.
Moderna is using its platform for developing mRNA medicines to bring up to 15 new products to market in the next 5 years—from a vaccine against RSV to individualized cancer treatments. In order to achieve its ambitions, Moderna has adopted a people-centric, technology-forward approach, constantly testing new technology and innovation that can increase human capacity and clinical performance.
Moderna adopted generative AI the same way Moderna adopts other technology: with the mindset of using the power of digital to maximize its positive impact on patients. To allow AI to flourish, they knew they needed to start with the user and invest in laying a strong foundation for change.
Moderna’s objective was to achieve 100% adoption and proficiency of generative AI by all its people with access to digital solutions in six months. “We believe in collective intelligence when it comes to paradigm changes,” said Miller, “it’s everyone together, everyone with a voice and nobody left behind.” For this, Moderna assigned a team of dedicated experts to drive a bespoke transformation program. Their approach combined individual, collective and structural change management initiatives.
Individual change management initiatives included in-depth research and listening programs, as well as trainings hosted in person, online and with dedicated AI learning companions. “Using AI to teach AI was key to our success”, Miller points out. Collective change management initiatives included an AI prompt contest to identify the top 100 AI power users who were then structured as a cohort of internal Generative AI Champions. Moderna’s culture of learning led to local office hours in every business line and geography, and scaled through an internal forum on AI, which now has 2,000 active weekly participants. Lastly, structural change management initiatives included engaging Moderna’s CEO and executive committee members to foster AI culture through leadership meetings and town halls as well as incentive programs and sponsored events with internal and external experts.
This work led to an early win with the launch of an internal AI chatbot tool, mChat, at the beginning of 2023. Built on OpenAI’s API, mChat was a success, adopted by more than 80% of employees across the company, building a solid foundation for the adoption of ChatGPT Enterprise.
With the launch of ChatGPT Enterprise, Moderna had a decision to make: continue developing mChat as an all-purpose AI tool, or give employees access to ChatGPT Enterprise?“
As a science-based company, we research everything,” said Brice Challamel, Head of AI Products and Platforms at Moderna. Challamel’s team did extensive user testing comparing mChat, Copilot, and ChatGPT Enterprise. “We found out that the net promoter score of ChatGPT Enterprise was through the roof. This was by far the company-favorite solution, and the one we decided to double down on,” Challamel said.
Once employees had a way to create their own GPTs easily, the only limit was their imaginations. “We were never here to fill a bucket, but to light a fire,” Challamel said. “We saw the fire spread, with hundreds of use cases creating positive value across teams. We knew we were on to something revolutionary for the company.”
The company’s results are beyond expectations. Within two months of the ChatGPT Enterprise adoption:
Moderna had 750 GPTs across the company
40% of weekly active users created GPTs
Each user has 120 ChatGPT Enterprise conversations per week on average
One of the many solutions Moderna has built and is continuing to develop and validate with ChatGPT Enterprise is a GPT pilot called Dose ID. Dose ID has the potential to review and analyze clinical data and is able to integrate and visualize large datasets. Dose ID is intended for use as a data-analysis assistant to the clinical study team, helping to augment the team’s clinical judgment and decision-making.
“Dose ID has provided supportive rationale for why we have picked a specific dose over other doses. It has allowed us to create customized data visualizations and it has also helped the study team members converse with the GPT to further analyze the data from multiple different angles,” said Meklit Workneh, Director of Clinical Development at Moderna.
Dose ID uses ChatGPT Enterprise’s advanced data analysis feature to automate the analysis and verify the optimal vaccine dose selected by the clinical study team, by applying standard dose selection criteria and principles. Dose ID provides a rationale, references its sources, and generates informative charts illustrating the key findings. This allows for a detailed review, led by humans and with AI input, prioritizing safety and optimizing the vaccine profile prior to further development in late-stage clinical trials.
“The Dose ID GPT has the potential to boost the amount of work we’re able to do as a team. We can comprehensively evaluate these extremely large amounts of data, and do it in a very efficient, safe, and accurate way, while helping to ensure security and privacy,” added Workneh.
Moderna’s legal team boasts 100% adoption of ChatGPT Enterprise. “It lets us focus our time and attention on those matters that are truly driving an impact for patients,” said Shannon Klinger, Moderna’s Chief Legal Officer.
Now, with the Contract Companion GPT, any function can get a clear, readable summary of a contract. The Policy Bot GPT helps employees get quick answers about internal policies without needing to search through hundreds of documents.
Moderna’s corporate brand team has also found many ways to take advantage of ChatGPT Enterprise. They have a GPT that helps prepare slides for quarterly earnings calls, and another GPT that helps convert biotech terminology into approachable language for investor communications.
“Sometimes we’re so in our own world, and AI helps the brand think beyond that,” explained Kate Cronin, Chief Brand Officer of Moderna. “What would my mother want to know about Moderna, versus a regulator, versus a doctor? How do we tell our story in an effective way across different audiences? That’s where I think there’s a huge opportunity.”
With an ambitious plan to launch multiple products in the next few years, Moderna sees AI as a key component to their success—and their ability to stay lean as a business while setting new benchmarks in innovation.
“If we had to do it the old biopharmaceutical ways, we might need a hundred thousand people today,” said Bancel. “We really believe we can maximize our impact on patients with a few thousand people, using technology and AI to scale the company.”
Moderna has been well positioned to leverage generative AI having spent the last decade building a robust tech stack and data platform. The company fosters a culture of learning and curiosity, attracting employees that excel in adopting new technologies and building AI-first solutions.
By making business processes at Moderna more efficient and accurate, the use of AI ultimately translates to better outcomes for patients. “I’m really thankful for the entire OpenAI team, and the time and engagement they have with our team, so that together we can save more lives,” Bancel said.
Kalman Tiboldi - CTO & Founder at GemOne-TVH - Simplify or Die: Why Complexity Is the Real IT Challenge
.png)
Isabelle Droll - CIO for Airline, Corporate, Hotels & Resorts and Sustainability at TUI - Data, Diversity, and Destinations
.png)
Sharon Prior - CIO in transition - How Great Tech Leadership Begins with Business Thinking
-1.jpg)
José Antonio López, Group CIO at TOUS - Jewels, Data & AI: Inside the Digital Transformation of TOUS
.png)
Tom Tanghe - General Manager ITC EMEA at Daikin Europe - Reinventing the CIO Role
.jpg)
CIOFEST 2025 - From Order Taker to Proactive Disruptor
Geopolitical tensions have dominated the headlines for over two years now. In this context, the cyber threat landscape is also evolving rapidly. The protection and security of critical infrastructure – both physical and digital – is becoming increasingly important.
.png?width=600&height=600&name=Anna%20Kopp%20(1).png)
